1. Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma
   Lu Zeng et al, 2020, BMC Medical Genomics CrossRef
2. Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways
   Hongjin Chen et al, 2022, Cancer Gene Therapy CrossRef
3. Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
   Fang Wang et al, 2021, Liver Research CrossRef
4. Importance of protein flexibility on molecular recognition: modeling binding mechanisms of aminopyrazine inhibitors to Nek2
   Xinyi Tang et al, 2018, Physical Chemistry Chemical Physics CrossRef
5. Dysregulation of Wnt/β‐catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application
   Qian Li et al, 2021, Cancer Science CrossRef
6. Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression
   Jing-Ran Su et al, 2016, World Journal of Gastroenterology CrossRef
7. Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options
   Alicja Czubaty et al, 2017, The International Journal of Biochemistry & Cell Biology CrossRef
8. KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC
   Chunxia Cheng et al, 2020, Cancer Management and Research CrossRef
9. Checking NEKs: Overcoming a Bottleneck in Human Diseases
   Andressa Peres de Oliveira et al, 2020, Molecules CrossRef
10. Chromatin, histones, and histone modifications in health and disease
    Sanket Shah et al, 2020, Genome Plasticity in Health and Disease CrossRef
11. In Mitosis You Are Not: The NIMA Family of Kinases in Aspergillus, Yeast, and Mammals
    Scott Bachus et al, 2022, International Journal of Molecular Sciences CrossRef
12. Decoding the Role of CD271 in Melanoma
    Anna Vidal et al, 2020, Cancers CrossRef
13. High expression of NEK2 promotes gastric cancer progression via activating AKT signaling
    Hao Wan et al, 2021, Journal of Physiology and Biochemistry CrossRef
14. Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices
    Shen Pan et al, 2019, Frontiers in Oncology CrossRef
15. Screening and Identification of Key Common and Specific Genes and Their Prognostic Roles in Different Molecular Subtypes of Breast Cancer
    Na Sun et al, 2021, Frontiers in Molecular Biosciences CrossRef
16. The NEK family of serine/threonine kinases as a biomarker for cancer
    Nagesh Kishan Panchal et al, 2022, Clinical and Experimental Medicine CrossRef
17. MicroRNA‐128 promotes apoptosis in lung cancer by directly targeting NIMA‐related kinase 2
    Dejian Zhao et al, 2017, Thoracic Cancer CrossRef
18. Identification of Key Pathways and Genes in the Dynamic Progression of HCC Based on WGCNA
    Li Yin et al, 2018, Genes CrossRef
19. microRNA‐128‐3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down‐regulating NEK2
    Yuanwen Chen et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
20. One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment
    Xing Huang et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
21. Early-stage biomarkers identification by integrated genomic analysis in Hepatocellular carcinoma
    Suryaa Manoharan et al, 2024, Medicine in Omics CrossRef
22. microRNA‐138 induces cell survival and reduces WNT/β‐catenin signaling of osteoarthritis chondrocytes through NEK2
    Weiling Xu et al, 2019, IUBMB Life CrossRef
23. High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms
    Ewelina Motylewska et al, 2020, Endocrine Pathology CrossRef